Search

We love our smartphones, but could they be harming our health? An MSK expert weighs in.

… Monday, May 20, 2019 Summary A government-funded study published last year raised concerns about the dangers of cell phone radiation. An MSK radiation expert discusses the study’s limitations and weighs in on the evidence related to cell phone use and cancer risk. Back in 1993, a Florida resident named

Read about a new treatment for leptomeningeal metastasis that is giving patients hope.

… Wednesday, January 28, 2026 VIDEO | 03:35 Watch How Two MSK Labs Came Together to Give a Stage 4 Lung Cancer Patient More Time Every cancer breakthrough begins years before it offers patients new hope. Our series Saved by Science takes you inside MSK’s world class research labs, where you’ll see patients

Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials.

… Friday, December 27, 2019 Summary Deep bonds are forged between MSK’s specialized nurses and their patients during first-in-human trials. It was Monday, July 2, 2018, and the early morning air in Manhattan was humid, thick with anticipation for the upcoming Independence Day holiday. Memorial Sloan Kettering

Androgen deprivation therapy may depress testosterone for prolonged periods in older patients, or those who are on the treatment for more than six months, increasing the risk of associated adverse events, according to the results of our recent retrospective study.

… Tuesday, October 8, 2019 Despite the intention to reduce testosterone temporarily, androgen deprivation therapy (ADT) may lower it for prolonged periods in patients over the age of 65 or those who take ADT for more than six months, according to the results of our recent retrospective study. Given the

More than 50,000 runners traversed 26.2 miles across five boroughs for the TCS New York City Marathon. Among them were 925 participants who ran in support of Fred’s Team. Fred’s Team is the running program for Memorial Sloan Kettering Cancer Center (MSK), which is dedicated to moving closer to a world without cancer.

… Friday, November 9, 2018 More than 50,000 runners traversed 26.2 miles across five boroughs for the TCS New York City Marathon. Among them were 925 participants who ran in support of Fred’s Team . Fred’s Team is the running program for Memorial Sloan Kettering Cancer Center (MSK), which is dedicated

… Friday, March 21, 2025 A newly published pooled analysis of the Organ Preservation in Patients with Rectal Adenocarcinoma (OPRA) trial and the CAO/ARO/AIO-12 trial by the German Rectal Cancer Study Group has confirmed the safety and benefits of the watch-and-wait strategy for patients with locally advanced

Learn about the latest guidelines for Pap tests, HPV tests, and pelvic exams — including recently updated recommendations.

… Thursday, February 14, 2019 Summary An MSK expert explains the recently updated recommendations for Pap tests, HPV tests, and pelvic exams. Regular screenings play a vital role in helping women prevent cervical cancer , which used to be one of the most common causes of death for women in the United States

Find out what an MSK gynecologist thinks you should know about birth control and cancer risk.

… Tuesday, September 25, 2018 Summary Gynecologist Deborah Goldfrank shares the facts about how hormonal birth control can affect a woman’s risk for cancer. When it comes to cancer risk, birth control sometimes gets a bad rap. “Usually when we talk about birth control and cancer, we’re talking about the

MSK researchers are reporting that a bacterial species called Blautia producta appears to release a substance that kills harmful bacteria.

… Wednesday, August 21, 2019 Summary A new study from Memorial Sloan Kettering reports the first evidence of a bacterial species that appears to help kill dangerous microbes in the gut. Hospital-acquired infections are a major threat, especially for people whose immune systems may be compromised because

In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute's Immunology Program, and medical oncologist and immunologist Jedd Wolchok.

… Friday, April 20, 2012 Summary In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok. In